Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00442169 · ClinicalTrials.gov registry record · Phase 2
Safety and Immunogenicity of ChimeriVax-WN02 West Nile Vaccine in Healthy Adults
A Phase 2 study of West Nile Fever, sponsored by Sanofi Pasteur, a Sanofi Company.
- Completed
- Registry status
- Phase 2
- Development phase
- 208
- Enrollment target
- 5
- Study locations
NCT00442169 is a Phase 2 study of West Nile Fever that has completed, run by Sanofi Pasteur, a Sanofi Company. The registered enrollment target is 208 participants. The trial reports 5 study locations across 5 states.
The verdict
NCT00442169, a Phase 2 study of West Nile Fever, has completed, sponsored by Sanofi Pasteur, a Sanofi Company.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 208 participants
- Enrollment target
- 5
- Study locations
Study Summary
The purpose of this study is to determine whether a single subcutaneous injection of ChimeriVax-WN02 vaccine is well tolerated, safe and induces protective antibodies against West Nile Disease. The study is divided into two parts; in the first part, a comparison of 3 dose levels of the vaccine will be made, with an inactive control. In the second part, the optimum dose level chosen after the first part will be given to older volunteers.
Conditions Studied
Interventions
- BIOLOGICAL ChimeriVax-WN02 Low Dose
- BIOLOGICAL ChimeriVax-WN02 Medium Dose
- BIOLOGICAL ChimeriVax-WN02 High Dose
- BIOLOGICAL 0.9% Saline solution
Study Locations (5)
Arizona
- HOPE Research Institute - Phoenix
Idaho
- Idaho Infectious Diseases, PLLC - Idaho Falls
Kansas
- PRA International Clinical Pharmacology Center - Lenexa
Missouri
- Bio-Kinetic Clinical Applications, Inc. - Springfield
Virginia
- The Glennan Centre for Geriatrics and Gerontologyy, EVMS - Norfolk
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 208 participants |
| Start Date | 2005-12 |
| Est. Completion | 2009-04 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00442169
The ClinicalTrials.gov registry entry for NCT00442169 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 208 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sanofi Pasteur, a Sanofi Company, which has 153 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with West Nile Fever appearing as the primary indexed condition, and to 4 interventions - of which ChimeriVax-WN02 Low Dose is the first listed.
NCT00442169 reports 5 study locations spanning 5 distinct geographic areas - top geographies include Arizona, Idaho, Kansas.
Frequently Asked Questions
What is clinical trial NCT00442169 about?
NCT00442169 is a clinical study titled "Safety and Immunogenicity of ChimeriVax-WN02 West Nile Vaccine in Healthy Adults". The purpose of this study is to determine whether a single subcutaneous injection of ChimeriVax-WN02 vaccine is well tolerated, safe and induces protective antibodies against West Nile Disease. The study is divided into two parts; in the first part, a comparison of 3 dose levels of the vaccine will ...
What is the current status of trial NCT00442169?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 208 participants. The study started on 2005-12. Estimated completion is 2009-04.
What conditions does trial NCT00442169 study?
This clinical trial studies the following conditions: West Nile Fever.
What interventions are being tested in trial NCT00442169?
The interventions under investigation include: ChimeriVax-WN02 Low Dose (BIOLOGICAL), ChimeriVax-WN02 Medium Dose (BIOLOGICAL), ChimeriVax-WN02 High Dose (BIOLOGICAL), 0.9% Saline solution (BIOLOGICAL).
Who is sponsoring clinical trial NCT00442169?
This trial is sponsored by Sanofi Pasteur, a Sanofi Company, which has 153 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00442169 being conducted?
This trial has 5 study locations across Arizona, Idaho, Kansas, Missouri, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for West Nile Fever
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.